Your browser doesn't support javascript.
loading
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer.
Goyal, Lipika; Chaudhary, Surendra Pal; Kwak, Eunice L; Abrams, Thomas A; Carpenter, Amanda N; Wolpin, Brian M; Wadlow, Raymond C; Allen, Jill N; Heist, Rebecca; McCleary, Nadine Jackson; Chan, Jennifer A; Goessling, Wolfram; Schrag, Deborah; Ng, Kimmie; Enzinger, Peter C; Ryan, David P; Clark, Jeffrey W.
Afiliación
  • Goyal L; Harvard Medical School, Boston, MA, USA.
  • Chaudhary SP; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA.
  • Kwak EL; Harvard Medical School, Boston, MA, USA. Schaudhary1@mgh.harvard.edu.
  • Abrams TA; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA. Schaudhary1@mgh.harvard.edu.
  • Carpenter AN; Harvard Medical School, Boston, MA, USA.
  • Wolpin BM; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA.
  • Wadlow RC; Harvard Medical School, Boston, MA, USA.
  • Allen JN; Dana Farber Cancer Institute, Boston, MA, USA.
  • Heist R; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA.
  • McCleary NJ; Harvard Medical School, Boston, MA, USA.
  • Chan JA; Dana Farber Cancer Institute, Boston, MA, USA.
  • Goessling W; Virginia Cancer Specialist, Fairfax, VA, USA.
  • Schrag D; Harvard Medical School, Boston, MA, USA.
  • Ng K; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA.
  • Enzinger PC; Harvard Medical School, Boston, MA, USA.
  • Ryan DP; Massachusetts General Hospital Cancer Center, 55 Fruit Street, 223 Bartlett Hall, Boston, 02114, MA, USA.
  • Clark JW; Harvard Medical School, Boston, MA, USA.
Invest New Drugs ; 38(5): 1533-1539, 2020 10.
Article en En | MEDLINE | ID: mdl-31898183

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Triazoles / Neoplasias Esofágicas / Proteínas HSP90 de Choque Térmico / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Triazoles / Neoplasias Esofágicas / Proteínas HSP90 de Choque Térmico / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos